Precision Epigenomics Inc was selected to present their findings regarding the development of a liquid biopsy assay for non-small cell lung to the leadership and faculty of the University of Arizona.
Recent Posts
- Exploring Early Cancer Detection with the EPISEEK™ Liquid Biopsy: Insights from Dr. Joshua Routh on the Beautifully Broken Podcast
- Dr. Richard Bernert and Dr. Dan Rubin discuss Catching Cancer Early: A Game Changer with EPISEEK™
- Precision Epigenomics Presents Validation of EPISEEK™, a Multi-Cancer Early Detection Test, at 2025 ASCO Annual Meeting
- Precision Epigenomics Highlighted by Tucson News 13 for Multi-Cancer Early Detection Blood Test Development
- Precision Epigenomics Shares Abstracts Showing Performance of Assays for Melanoma and Brain Cancer Detection
Recent Comments
No comments to show.